Stocks Trending: PrivateBancorp, Inc., General Communication (NASDAQ:GNCMA), Blucora (NASDAQ:BCOR), OncoGenex Pharmaceuticals (NASDAQ:OGXI)

Huntington Ingalls Industries, Inc. (NYSE:HII) shares increased 1.87% in last trading session and ended the day at $127.22. HII Gross Margin is 22.10% and its has a return on assets of 6.50%. Huntington Ingalls Industries, Inc. (NYSE:HII) quarterly performance is 14.56%.

Huntington Ingalls Industries’ (NYSE:HII) Ingalls Shipbuilding division hosted Adm. John Richardson Thursday as part of his visit to shipyards in the region. This was his first visit to Ingalls as Chief of Naval Operations. Richardson received updates on Ingalls’ shipbuilding programs and toured the facility.

PrivateBancorp, Inc. (NASDAQ:PVTB) ended the last trading day at $37.45. Company weekly volatility is calculated as 4.17% and price to cash ratio as 6.33. PrivateBancorp, Inc. (NASDAQ:PVTB) showed a weekly performance of -8.70%.

PrivateBancorp, Inc. (NASDAQ:PVTB) announced it intends to release its fourth quarter and full year 2015 earnings on January 21, 2016, before the market open. The company will host a conference call for investors and analysts at 11 a.m. ET (10 a.m. CT) on the same day. The call-in number is (888) 782-9127 (U.S. and Canada) or (706) 634-5643 (International).

On 08 January, General Communication Inc. (NASDAQ:GNCMA) shares moved down -3.13% and was closed at $18.60. GNCMA EPS growth in last 5 year was 24.60%. General Communication Inc. (NASDAQ:GNCMA) year to date (YTD) performance is -5.97%.

Blucora, Inc. (NASDAQ:BCOR) shares moved down -7.26% in last trading session and ended the day at $8.68. BCOR Gross Margin is 50.40% and its has a return on assets of -6.00%. Blucora, Inc. (NASDAQ:BCOR) quarterly performance is -40.01%.

Blucora, Inc. (NASDAQ:BCOR) announced that it has completed the acquisition of the parent company of HD Vest Financial Services® (“HD Vest”), the holding company for the operating subsidiaries providing financial services under the HD Vest name. HD Vest Investment ServicesSM is the leading independent broker-dealer providing wealth management and advisory solutions specifically for tax professionals

OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) caters to the Healthcare space. Its weekly performance is -15.70%. On the last day of trading company shares ended up at $1.02. OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) distance from 50-day simple moving average (SMA50) is -8.98%.

On January 5, 2016, Ionis Pharmaceuticals, Inc. filed a lawsuit against our subsidiary OncoGenex Technologies, Inc. (NASDAQ:OGXI) in the United States District Court for the Southern District of California. Ionis claims that OGX is in breach of an Amended and Restated License Agreement between Ionis and OGX dated July 2, 2008, as amended (the “License Agreement”). Under the License Agreement, Ionis is entitled to a share of certain forms of non-royalty revenue received by OGX, but is not entitled to a share of revenue received by OGX for the reimbursement of research and development activities.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *